Author:
Capitanio Umberto,Suardi Nazareno
Publisher
Springer Science and Business Media LLC
Reference10 articles.
1. Dall'Era, M. A. et al. Surgical management after active surveillance for low-risk prostate cancer: pathological outcomes compared with men undergoing immediate treatment. BJU Int. doi:10.1111/j.1464–410.X.2010.09589.x.
2. Chun, F. K. et al. Development and internal validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology. Eur. Urol. 49, 820–826 (2006).
3. Heidenreich, A. et al. EAU guidelines on prostate cancer. part 1: screening, diagnosis, and treatment of clinically localised disease. Eur. Urol. 59, 61–71 (2011).
4. Capitanio, U. et al. Biopsy core number represents one of foremost predictors of clinically significant gleason sum upgrading in patients with low-risk prostate cancer. Urology 73, 1087–1091 (2009).
5. van den Bergh, R. C. et al. Outcomes of men with screen-detected prostate cancer eligible for active surveillance who were managed expectantly. Eur. Urol. 55, 1–8 (2009).
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献